- Home
- MLYS vs AMSC Comparison
MLYS vs AMSC Comparison
Compare MLYS & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- AMSC
- Stock Information
- Founded
- MLYS 2019
- AMSC 1987
- Country
- MLYS United States
- AMSC United States
- Employees
- MLYS N/A
- AMSC N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- AMSC Metal Fabrications
- Sector
- MLYS Health Care
- AMSC Consumer Discretionary
- Exchange
- MLYS Nasdaq
- AMSC Nasdaq
- Market Cap
- MLYS 3.1B
- AMSC 2.7B
- IPO Year
- MLYS 2023
- AMSC 1991
- Fundamental
- Price
- MLYS $40.00
- AMSC $59.74
- Analyst Decision
- MLYS Strong Buy
- AMSC Buy
- Analyst Count
- MLYS 6
- AMSC 1
- Target Price
- MLYS $42.60
- AMSC $39.00
- AVG Volume (30 Days)
- MLYS 1.3M
- AMSC 1.2M
- Earning Date
- MLYS 11-10-2025
- AMSC 10-29-2025
- Dividend Yield
- MLYS N/A
- AMSC N/A
- EPS Growth
- MLYS N/A
- AMSC N/A
- EPS
- MLYS N/A
- AMSC 0.39
- Revenue
- MLYS N/A
- AMSC $254,886,000.00
- Revenue This Year
- MLYS N/A
- AMSC $28.23
- Revenue Next Year
- MLYS N/A
- AMSC $11.78
- P/E Ratio
- MLYS N/A
- AMSC $150.95
- Revenue Growth
- MLYS N/A
- AMSC 63.73
- 52 Week Low
- MLYS $8.24
- AMSC $13.98
- 52 Week High
- MLYS $44.80
- AMSC $70.49
- Technical
- Relative Strength Index (RSI)
- MLYS 53.93
- AMSC 52.16
- Support Level
- MLYS $41.74
- AMSC $52.75
- Resistance Level
- MLYS $44.60
- AMSC $63.70
- Average True Range (ATR)
- MLYS 2.22
- AMSC 5.20
- MACD
- MLYS -0.83
- AMSC -0.72
- Stochastic Oscillator
- MLYS 46.44
- AMSC 42.57
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.